Delivery Order SPE2DB24D9313-SPE2DB25FFFGP

Award Date 10/30/24
Potential Completion Date 11/21/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the supply of Mirena 52 mg Systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,776.00 firm fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $2,603.85 award is for the delivery of Mirena 52 mg contraceptive systems to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,124.68 firm fixed-price delivery order is for the supply of 52 mg Mirena systems, a type of intrauterine contraceptive device. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB24 program. The contract, valued at $2,960.00, is for the delivery of Mirena 52 mg intrauterine systems, a contraceptive product. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a wide range of medical supplies and pharmaceuticals to the U.S. Department of Defense (DoD)...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,184.00 firm fixed-price delivery order is for the supply of Mirena 52 mg intrauterine contraceptive systems. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical indefinite delivery contract (IDC) valued at up to $499,999,999. The contract provides for the delivery of Mirena 52 mg contraceptive systems to the DLA, which supports the recurring medical supply needs of military health facilities worldwide. The fixed-price delivery order is valued at $15,392 and has a completion date of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DX program. The $11,840.00 firm fixed-price award is for the supply of Mirena 52 mg intrauterine systems, a hormonal contraceptive device, to support the recurring medical supply needs of U.S. military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 single-award indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $5,920.00 awarded by the Defense Logistics Agency (DLA) under the SPE2DB program. The order is for the supply of Mirena 52 mg systems, a contraceptive device, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is an established federal contractor that supplies a wide range of pharmaceutical products,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,840.00 firm fixed-price delivery order is for the supply of Mirena 52 mg systems, a contraceptive product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical items to fulfill the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB program. The $2,960.00 contract is for the supply of 4565657781 - Mirena 52 MG Systems, a contraceptive device, to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) DMS Pharmaceutical Group holds with the Defense Logistics Agency...
  • SPE2DB24D9313
    Indefinite Delivery Contract
  • SPE2DB24D9313-SPE2DB25FFFGP
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $3,552.00 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The delivery order is for the supply of Mirena 52 mg intrauterine contraceptive systems. This award is not associated with any set-aside designation.

DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 1/29/25, 9:22 AM